Your browser doesn't support javascript.
Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts.
Pahalyants, Vartan; Murphy, William S; Klebanov, Nikolai; Lu, Chenyue; Theodosakis, Nicholas; Klevens, R Monina; Estir, Hossein; Lilly, Evelyn; Asgari, Maryam; Semenov, Yevgeniy R.
  • Pahalyants V; Department of Dermatology, Massachusetts General Hospital, Boston; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
  • Murphy WS; Department of Dermatology, Massachusetts General Hospital, Boston.
  • Klebanov N; Department of Dermatology, Massachusetts General Hospital, Boston.
  • Lu C; Department of Dermatology, Massachusetts General Hospital, Boston.
  • Theodosakis N; Department of Dermatology, Massachusetts General Hospital, Boston.
  • Klevens RM; Massachusetts Department of Public Health, Bureau of Infectious Disease and Laboratory Sciences, Boston.
  • Estir H; Laboratory of Computer Science, Massachusetts General Hospital, Boston; Department of Medicine, Massachusetts General Hospital, Boston.
  • Lilly E; Department of Dermatology, Massachusetts General Hospital, Boston.
  • Asgari M; Department of Dermatology, Massachusetts General Hospital, Boston.
  • Semenov YR; Department of Dermatology, Massachusetts General Hospital, Boston. Electronic address: ysemenov@mgh.harvard.edu.
J Am Acad Dermatol ; 86(1): 252-255, 2022 01.
Article in English | MEDLINE | ID: covidwho-1401553

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biological Products / COVID-19 / Immunosuppressive Agents Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: J Am Acad Dermatol Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Biological Products / COVID-19 / Immunosuppressive Agents Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: J Am Acad Dermatol Year: 2022 Document Type: Article